Recent Finacing
Recent Raise
ForSight VISION5 develops the Helios non-invasive ocular insert for sustained drug delivery in anterior segment diseases (glaucoma, dry eye, allergy) and is in a randomized Phase 2 study.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors